Cargando…
Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?
Autor principal: | Tarantino, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631528/ https://www.ncbi.nlm.nih.gov/pubmed/23610586 http://dx.doi.org/10.5812/hepatmon.7560 |
Ejemplares similares
-
Silver Lining and Sage Advise
por: Yesudian, Patrick
Publicado: (2013) -
NASH‐related cirrhosis: An occult liver disease burden
por: Arrese, Marco, et al.
Publicado: (2017) -
Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
por: Hirsova, Petra
Publicado: (2021) -
Insulin Resistance: Quest for Surrogate Markers
por: Mahajan, Rajiv
Publicado: (2017) -
Functional Neuroimaging in Patients With Disorders of Consciousness: Caution Advised
por: Elwell, Clare
Publicado: (2023)